M&T Bank’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$257K Sell
2,982
-914
-23% -$82.1K ﹤0.01% 1521
2026
Q2
$372K Sell
3,896
-2,760
-41% -$251K ﹤0.01% 1355
2026
Q1
$641K Buy
+6,656
New +$666K ﹤0.01% 1020

Other funds holding IRMD

M&T Bank's IRMD Position: Q3 2026 in Review

M&T Bank reduced its iRadimed (IRMD) stake by 23% in Q3 2026, selling an estimated $82.1K and leaving 2,982 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1521.

M&T Bank first reported a position in IRMD in Q1 2026 and has held it in 3 quarters since. The position peaked at $641K in Q1 2026. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • M&T Bank held 2,982 shares of iRadimed worth $257K as of Q3 2026.
  • M&T Bank sold 914 iRadimed shares in Q3 2026, an estimated $82.1K.
  • iRadimed made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1521 holding.
  • M&T Bank first reported a position in iRadimed in Q1 2026 and has held it in 3 quarters since.
  • M&T Bank's iRadimed position peaked at $641K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.